ANNX logo

Annexin Pharmaceuticals AB (publ) Stock Price

OM:ANNX Community·SEK 162.4m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

ANNX Share Price Performance

SEK 23.00
-24.00 (-51.06%)
SEK 23.00
-24.00 (-51.06%)
Price SEK 23.00

ANNX Community Narratives

There are no narratives available yet.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with reasonable growth potential.

5 Risks
2 Rewards

Annexin Pharmaceuticals AB (publ) Key Details

SEK 0

Revenue

SEK 0

Cost of Revenue

SEK 0

Gross Profit

SEK 38.7m

Other Expenses

-SEK 38.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-5.49
0%
0%
0%
View Full Analysis

About ANNX

Founded
2014
Employees
4
CEO
Anders Haegerstrand
WebsiteView website
www.annexinpharma.com/sv

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden.

Recent ANNX News & Updates

Recent updates

No updates